Showing 2 of 2 recruiting trials for “hereditary-pulmonary-alveolar-proteinosis”
Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP).
👨⚕️ Matthias Griese, MD,, Ludwig Maximilians Universität München📍 1 site📅 Started Oct 2025View details ↗
Safety and Efficacy of PMT Therapy of hPAP
👨⚕️ Christopher Towe, MD, Children's Hospital Medical Center, Cincinnati📍 1 site📅 Started Jun 2023View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →